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Background: We have previously shown that the P. gingivalis HmuY hemophore-like protein binds heme and
scavenges heme from host hemoproteins to further deliver it to the cognate heme receptor HmuR. The aim of
this study was to characterize structural features of HmuY variants in the presence and absence of heme with
respect to roles of tryptophan residues in conformational stability.
Results: HmuY possesses tryptophan residues at positions 51 and 73, which are conserved in HmuY homologs
present in a variety of bacteria, and a tryptophan residue at position 161, which has been found only in HmuY
identified in P. gingivalis strains. We expressed and purified the wildtype HmuY and its protein variants with
single tryptophan residues replaced by alanine or tyrosine residues. All HmuY variants were subjected to
thermal denaturation and fluorescence spectroscopy analyses. Replacement of the most buried W161 only
moderately affects protein stability. The most profound effect of the lack of a large hydrophobic side chain in
respect to thermal stability is observed for W73. Also replacement of the W51 exposed on the surface results in
the greatest loss of protein stability and even the large aromatic side chain of a tyrosine residue has little
potential to substitute this tryptophan residue. Heme binding leads to different exposure of the tryptophan
residue at position 51 to the surface of the protein. Differences in structural stability of HmuY variants suggest
the change of the tertiary structure of the protein upon heme binding.
Conclusions: Here we demonstrate differential roles of tryptophan residues in the protein conformational
stability. We also propose different conformations of apo- and holoHmuY caused by tertiary changes which
allow heme binding to the protein.
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Periodontitis is an infectious disease in which genetic,
microbial, immunological, and environmental factors
combine to influence disease risk and progression,
resulting in the destruction of tooth-supporting tissues
[1,2]. There is growing evidence showing that a number
of complex human diseases are caused or are influenced
by periodontal diseases, including cardiovascular and re-
spiratory diseases, diabetes mellitus, osteoporosis, and
rheumatoid arthritis [3,4]. A major etiological agent in the
development and progression of chronic periodontitis is* Correspondence: Teresa.Olczak@biotech.uni.wroc.pl
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unless otherwise stated.Porphyromonas gingivalis, a black-pigmented Gram-
negative anaerobic bacterium [1].
Establishment of infection by pathogens depends on a
readily available iron, and for some bacteria a heme
source. However, iron and heme availability is limited in
the host environment and therefore bacteria evolved so-
phisticated systems to acquire these compounds from
host hemoproteins. Among them, Gram-negative bac-
teria utilize outer-membrane receptors directly or with
the assistance of a hemophore [5-9]. Unlike other Gram-
negative bacteria, P. gingivalis does not produce and
utilize siderophores. The bacterium also lacks the major-
ity of enzymes of the biosynthetic pathway for heme bio-
synthesis. Therefore, P. gingivalis must acquire heme as a
sole source of iron and protoporphyrin IX. In P. gingivalis,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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heme utilization have been described, including HmuR,
Tlr, IhtA, and HusB [5,8]. The best characterized sys-
tem of heme acquisition in P. gingivalis consists of
proteins encoded by hmu operon, comprising the HmuR
and HmuY proteins. HmuR is an outer-membrane TonB-
dependent receptor involved in heme transport through
the outer membrane [10-13], whereas HmuY is a
membrane-associated heme-binding lipoprotein [14-16].
We reported that HmuY binds iron(III) protoporphyrin
IX and iron(II) protoporphyrin IX at 1:1 molar ratio
[14,15]. Detailed characterization of the HmuY-heme
complex demonstrated that heme, with a midpoint poten-
tial of 136 mV, is in a low-spin Fe(III) hexa-coordinate en-
vironment [17]. In that report we identified histidine
residues at positions 134 and 166 as potential heme li-
gands. Crystallographic analysis determined unique beta-
fold HmuY protein structure and confirmed engagement
of H134 and H166 in heme binding [18]. We also demon-
strated that HmuY binds iron(III) mesoporphyrin IX and
iron(III) deuteroporphyrin IX in an analogous way to
heme [19]. The only differences observed were two forms
of HmuY-iron(III) deuteroporphyrin IX complex differing
by a 180° rotation of porphyrin around the α-γ-meso-
carbon axis. Recently we showed that HmuY forms
complexes with non-iron metalloporphyrins, though
recognition of the ligand by HmuY depends on the
central metal ion [20]. Among them, Ga(III)PPIX, Co
(III)PPIX, and Cu(II)PPIX exhibited antimicrobial activity
against P. gingivalis [21]. Similar to hemophores, HmuY
was demonstrated to wrest heme from methemoglobin
[9,22]. Heme extraction from oxyhemoglobin was facili-
tated after oxidation to methemoglobin by pre-treatment
with P. gingivalis R-gingipain A (HRgpA) and K-gingipain
(Kgp) [9] or Prevotella intermedia interpain A [22]. Heme
uptake served by HmuR receptor and hemophore-likeTable 1 Primers designed and used in this study
Construct Mutation Template Primer n
HY11W51A W51A pHmuY11 HY11W51
HY11W51
HY11W73A W73A pHmuY11 HY11W73
HY11W73
HY11W161A W161A pHmuY11 HY11W16
HY11W16
HY11W51Y W51Y pHmuY11 HY11W51
HY11W51
HY11W73Y W73Y pHmuY11 HY11W73
HY11W73
HY11W161Y W161Y pHmuY11 HY11W16
HY11W16HmuY lipoprotein is novel and has been identified for the
first time in P. gingivalis.
In this work we report structural features of HmuY
variants and the protein’s conformational changes in-
duced by temperature and studied by means of fluores-
cence spectroscopy. Studies presented in this work have
been performed using the wildtype HmuY protein and
its variants with single tryptophan residues replaced by
alanine or tyrosine residues. Due to the widespread loca-
tion of tryptophan residues in HmuY, one could expect
that observation of tryptophan fluorescence spectra
could help to explain local structural stability of the pro-
tein and conformational changes accompanying ligand
binding.
Methods
Site-directed mutagenesis and protein purification
The DNA sequence encoding P. gingivalis HmuY poly-
peptide part lacking the first 25 residues (NCBI accession
no. CAM 31898) and cloned into pHmuY11 plasmid [15]
served as a template for mutagenesis. Single tryptophan
residues were replaced by alanine or tyrosine residues
using QuikChange II XL Site-Directed Mutagenesis Kit
(Stratagene). Primers designed and used in this study are
listed in Table 1. All HmuY protein variants were overex-
pressed using respective plasmids and Escherichia coli
ER2566 cells (New England Biolabs), and purified from a
soluble fraction of E. coli lysates as previously described
[16]. Molecular modeling of HmuY protein variants was
performed with the GROMOS96 implementation of
Swiss-PdbViewer (version 4.1).
Preparation of holoproteins
Hemin (Hemin chloride; ICN Biomedicals) solutions
were prepared and UV-visible titration experiments were
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with heme in the molar ratio 1:1.2. Excess heme was
separated by gel filtration using a PD-10 desalting
column (Amersham Pharmacia) or Zeba Spin Desalting
Columns (Thermo Scientific). HmuY concentration was
determined spectrophotometrically using the empirical
extinction coefficients ε280 = 36.68 mM
-1 cm-1 and ε280 =
59.26 mM-1 cm-1 for apo- and holoform, respectively,
determined as reported previously [17,20]. Extinction
coefficients of HmuY variants constructed in this study
were calculated analogously using the following equation:
ε280N ¼ ε280D AN280AD280
 
where ε280D is the theoretical extinction coefficient
(www.expasy.org) whilst AN280 and AD280 are absor-
bancies of native and unfolded protein in 20 mM phos-
phate buffer pH 7.4, containing 20 mM NaCl and the
same buffer containing 6 M guanidine hydrochloride
(Gdn-HCl; MP Biomedicals), respectively. The empirical
extinction coefficients are as follows: ε280 = 32.16, 27.75,
27.66, 30.82, 29.37, 28.45 mM-1 cm-1 for W51A, W73A,
W161A, W51Y, W73Y, W161Y, respectively. Titration
curves were analyzed using equations for a one-site
binding model and Kd values determined as reported
earlier [19] using the OriginPro 8 software (OriginPro
Corporation).
Circular dichroism (CD) spectroscopy
Far-UV CD spectroscopy was carried out using a Jasco
J-810 spectropolarimeter. Protein samples at 2 μM con-
centration in 20 mM sodium phosphate buffer, pH 7.4,
were measured in a 10-mm path-length cell. The spectra
were recorded over a wavelength range of 190–260 nm
by signal averaging of four spectra. Scanning speed of
100 nm/min and step resolution of 1 nm were used. All
spectra were baseline corrected for respective buffers.
Intrinsic tryptophan fluorescence spectroscopy
Intrinsic tryptophan fluorescence emission spectra were
recorded using a Jasco FP750 spectrofluorometer. Pro-
tein samples at 4 μM concentration in 20 mM sodium
phosphate buffer, pH 7.4, containing 20 mM NaCl were
excited at 295 nm and emission spectra were recorded
in the range of 300–450 nm, at a scanning interval of
1 nm and integration time of 1 s. All spectra were base-
line corrected for respective buffers. For analysis of
heme binding, 4 μM protein samples in 20 mM sodium
phosphate buffer, pH 7.4, containing 20 mM NaCl were
titrated with 1-μl aliquots of 1 mM hemin prepared as
described previously [17]. Fluorescence was determined
at excitation at 295 nm and emission at 329 nm.Thermal denaturation
Unfolding experiments were performed according to
standard protocols with modifications described previ-
ously [18]. Changes in intrinsic tryptophan fluorescence
emission spectra due to thermally induced protein
unfolding were monitored at 315 nm for excitation at
295 nm using a Jasco FP750 spectrofluorometer. Protein
samples at concentration of 4 μM in 20 mM sodium
phosphate buffer, pH 6.5, containing 20 mM NaCl and
1 M GdnHCl [18] were heated (22°C–85°C) in 10-mm
path-length cells with time/temperature interval of 1°C
per minute.
Sypro Orange (SYPRO ORANGE protein gel stain,
Invitrogen) exhibits intensive fluorescence when bound
to hydrophobic residues of proteins and therefore it was
used as a probe for thermal unfolding of HmuY. Samples
of 40 μM proteins in 20 mM sodium phosphate buffer,
pH 7.4, containing 20 mM NaCl were placed in a 96-well
qPCR plate and Sypro Orange was then added according
to the manufacturer’s instructions (Invitrogen). After 1-h
equilibration at 25°C the plate was heated up to 80°C in
an Mx3005P thermocycler (Agilent Technologies) with a
rate of 0.5°C per 30 s. Fluorescence was monitored by a
single photomultiplier tube (PMT) detector using a FROX
filter (excitation wavelength 585 nm, emission wavelength
610 nm). Fluorescence data were transformed to yield the
relative fraction of unfolded protein [18].
Results and discussion
P. gingivalis HmuY possesses three tryptophan residues
at positions 51, 73 and 161 [18], evenly distributed in
the polypeptide chain and protein structure; W161 is
buried in the interior of the heme binding cavity
whilst W73 and W51 are located closer to the protein
surface at the loops between β-strands forming the
central twisted β-sandwich structure of the holoH-
muY (Figure 1). Furthermore, W51 is partially ex-
posed on the holoHmuY surface just at the joint of
the protein core and a protruding β-hairpin, forming
a heme binding site that contains H134, one of the
iron coordinating histidines [17,18]. Due to the wide-
spread location of tryptophan residues one could ex-
pect that observation of tryptophan fluorescence
spectra can help to explain local structural stability of
the protein and conformational changes accompany-
ing ligand binding. Therefore we constructed protein
variants of the HmuY protein with single tryptophan
residues replaced either by alanine or tyrosine resi-
dues (namely W51A or W51Y, W73A or W73Y, and
W161A or W161Y). In this study, we attempted to
obtain a maximum effect of lacking a tryptophan side
chain on structural stability of the protein by replacing it
with an alanine residue. In contrast, tyrosine substitution
was expected to preserve the minimal free energy of the
Figure 1 Structure of heme-bound HmuY (PDB code: 3H8T).
Stick representation of tryptophan side chains with a defined color
for each structure is shown. α-helices are marked in red, β-strands in
blue, loops in orange, tryptophan residues in cyan, and axial histidine
residues in purple.
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structural changes were imposed by some aminoacid
replacements, as observed from far-UV CD spectra
(Additional file 1: Figure S1), they did not significantly
affect HmuY function since all protein variants pre-
served highly similar affinity to heme binding com-
pared to the wildtype protein, as examined by fluorescence
analysis (Additional file 2: Figure S2) and determination of
heme dissociation constants (0.216 ± 0.007 μM, 0.238 ±
0.012 μM, 0.235 ± 0.011 μM for W51Y, W73Y, W161Y, re-
spectively and 0.303 ± 0.013 μM, 0.229 ± 0.008 μM, 0.323 ±
0.016 μM for W51A, W73A, W161A, respectively, com-
pared with 0.296 ± 0.012 μM for the wildtype HmuY).
A tryptophan in a hydrophobic environment exhibits a
maximum wavelength of the fluorescence emission spec-
tra at 320–335 nm, while in a hydrophilic or exposed
environment it exhibits a maximum at 340–360 nm
[23]. Therefore intrinsic fluorescence emission, by select-
ive excitation of tryptophan residues, was used to probe
local conformational fluctuations in HmuY. When ex-
cited at 295 nm, all proteins show rather wide fluores-
cence emission spectra. The wildtype HmuY and all but
the W51Y protein variants show maxima within a wave-
length range from 328 to 330 nm. However, tyrosine
substitution of the apo-form of W51 results in slight
blue shift of the spectrum maximum to 325 nm. It is
again in good agreement with W51 being exposed to the
more polar environment. Interestingly, W51A mutant
has a maximum at 328 nm, which may result from
structural differences of the protein variant imposed by
the lack of a large aromatic side chain on the protein
surface that normally would make the structure more
rigid, protecting it from penetration by solvent molecules.Heme binding results in quenching of HmuY intrinsic
fluorescence and holoHmuY retains about 14% of the
fluorescence intensity of the apoform (Figure 2). Spectra
of the wildtype holoHmuY and substituted holoW51 or
holoW161 are comparable. In contrast, W73A and
W73Y protein variants reflect only about 5% of initial
apoHmuY intensity after heme binding. It is noteworthy
that replacement of W73 has a different effect on the
apo- and holoform of the protein. (Figure 2), pointing to
W73 fluorescence being quenched more severely in the
HmuY-heme complex with greater exposure to the
hydrophilic exterior of holoHmuY in comparison to
apoHmuY.
While W161 is the most buried tryptophan residue in
the protein core its impact on fluorescence spectra of
native protein is marginal. Both alanine and tyrosine
W161 variants have almost identical fluorescence spec-
tra as the wildtype HmuY (Figure 2), which implicates
that W161 residue is completely quenched. This may be
due to aromatic ring π stacking between W161 and
proximal F194. In addition, high energy states of W161
indoile group can be discharged by formation of the
hydrogen bond between side ring nitrogen of W161 and
the main chain carbonyl oxygen of Y80. Similarity in
spectra of apoHmuY and holoHmuY as well as of W161
variants suggest that both hydrogen bond and trypto-
phan and phenylalanine ring arrangements remain the
same in both protein forms.
Substitution of W51 or W73 by either a tyrosine or an
alanine residue results in loss of about 18% or 60% of
apoHmuY fluorescence intensity (Figure 2). W51 and
W73 residues are located in close proximity to each
other and in holoHmuY, as can be seen in the crystal
structure [18], W51 being the most exposed tryptohpan
residue to a more hydrophilic environment on the pro-
tein surface. Therefore energy from W73 can be trans-
ferred to W51 and then quenched due to the polar
environment of the latter. This also explains why fluor-
escence spectra of each protein variant do not sum to
the spectra of the wildtype protein. Since W161 seems
not to contribute to the spectra of apoHmuY, W51A,
W73A, W51Y and W73Y can serve as representatives
for protein variants where only fluorescence emission
spectra of W73 or W51, respectively, can be observed.
We assumed that spectra of W73A and W73Y simply
represent fluorescence of W51 whilst spectra of W51A
and W51Y correspond to fluorescence intensity of W73
when none of its energy is transferred to W51. Thus, it
has been useful for observation of HmuY thermal
unfolding and concluding conformational changes ac-
companying ligand binding.
Our predictions were well reflected in the experimen-
tal observations from HmuY thermal unfolding experi-
ments and alanine substitutions of tryptophan residues
Figure 2 Intrinsic tryptophan fluorescence spectra of apoform and holoform of HmuY alanine-substituted (A) and tyrosine-substituted
(B) protein variants. Emission spectra of 4 μM protein samples in 20 mM sodium phosphate buffer, pH 7.4, containing 20 mM NaCl were
recorded between 300 and 450 nm at excitation at 295 nm. Overlapping curves marked with arrows correspond to (A) holoHmuY, holoW51A,
and holoW161A or (B) holoHmuY, holoW51Y, and holoW161Y. Representative data out of three independent experiments are shown.
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structure compared with tyrosine substitutions (Figure 3).
The most profound effect of the lack of a large hydro-
phobic side chain was observed for W73 as the differ-
ence in Tm between apoW73Y (54.11 ± 0.051°C) and
apoW73A (39.45 ± 0.055°C) was 15°C (Figure 3A). The
same differences for protein variants with affected
W51Y (45.21 ± 0.031°C) or W51A (37.64 ± 0.043°C) and
W161Y (58.81 ± 0.066°C) or W161A (48.81 ± 0.039°C)
were 8°C and 10°C, respectively (Figure 3A). This ten-
dency was preserved for heme-loaded proteins (Figure 3B):
W73Y (60.11 ± 0.079°C) or W73A (46.09 ± 0.10°C), W51Y
(50.53 ± 0.04°C) or W51A (44.41 ± 0.057°C), W161Y
(62.12 ± 0.054°C) or W161A (52.12 ± 0.06°C). In all cases,replacement of the W51 exposed on the surface resulted
in significant loss of protein stability and even the large
aromatic side chain of a tyrosine residue had little poten-
tial to substitute this tryptophan residue. In contrast,
replacement of the most buried W161 with a tyrosine
residue only moderately affects protein stability: apoW161Y
(58.81 ± 0.066°C) or holoW161Y (62.12 ± 0.054°C) versus
apoHmuY (60.38 ± 0.095°C) or holoHmuY (63.45 ± 0.11°C).
Alanine substitution of W161 showed a greater effect on
HmuY stability, but W161A still remained the most stable
of all alanine-substituted variants (48.81 ± 0.039°C and
52.13 ± 0.062°C, for apo- and holoprotein, respectively). It is
worth noting that W51 and W73 of HmuY, compared with
W161, which is unique for P. gingivalis, are conserved
Figure 3 Normalized equilibrium curves of apoform (A) and holoform (B) of HmuY protein variants. Denaturation was carried out using
4 μM protein samples in 20 mM sodium phosphate buffer, pH 6.5, containing 20 mM NaCl and 1 M GdnHCl. Samples ware heated in 10-mm
path-length cells with a rate of 1°C per min. Spectra ware monitored with excitation at 295 nm and emission at 315 nm. Representative data out
of three independent experiments performed in triplicate are shown.
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other bacteria [16,24]. We suspect that they may be import-
ant for conformational stability of HmuY protein and par-
ticipate in tertiary changes allowing heme binding.
Thermal unfolding of HmuY protein variants was further
monitored using Sypro Orange fluorescence (Figure 4).
Interestingly, apoW161Y mutant unfolds analogously to
the wildtype apoHmuY (66.82 ± 0.48°C versus 69.55 ±
0.31°C) (Figure 4A). Heme binding raises W73Y stability
to the level of the wildtype apoprotein (Figure 4B). Lack of
compensation of the destabilization introduced by re-
placement of the W51 residue by ligand binding empha-
sizes the key role of this residue in preserving protein
folding. In general, higher Tm values were observed forprocesses monitored with Sypro Orange probe. Discrep-
ancies between melting temperatures obtained using dif-
ferent techniques may result from different phenomena
being observed. Sypro Orange binds to the denaturing
protein and offers the possibility to observe general expos-
ure of hydrophobic side chains to the solvent whilst
changes in intrinsic protein emission fluorescence are sen-
sitive to local environment distortions around selected
tryptophan residues. One may also not exclude possibility
that differences observed may result from different buffers
used. Previously, we reported that thermal denaturation of
HmuY in 20 mM sodium phosphate buffer, containing
20 mM NaCl was irreversible, leading to protein precipita-
tion [18], but addition of 1 M GdnHCl resulted in a
Figure 4 Normalized equilibrium curves of apoform (A) and holoform (B) of HmuY protein variants. Protein samples at concentration
40 μM in 20 mM sodium phosphate buffer, pH 7.4, containing 20 mM NaCl and Sypro Orange were heated from 25°C to 80°C with a rate of 0.5°C
per 30 s. Probe fluorescence was monitored with excitation at 585 nm and emission at 610 nm. Representative data out of three independent
experiments performed in triplicate are shown.
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holoHmuY preserved their native conformations and
holo-HmuY retained bound heme [18], thus demon-
strating that under the concentration used GdnHCl
did not cause protein denaturation and allowed ana-
lysis of HmuY stability using intrinsic fluorescence. To
analyze general denaturation process using SyproOr-
ange fluorescence, 1 M GdnHCl was omitted because
it interferes with the probe.
Finally, it should be noted that HmuY may function as
monomer and, especially after heme binding, may form
dimers and tetramers [15,18]. Therefore, influence of
oligomerization on protein stability and heme transfer
should be taken into consideration. However, in thisstudy we assumed that under conditions used (protein
concentration at 4–40 μM) HmuY is present in solutions
in the form of a monomer. Such assessment was based
on our preliminary, unpublished data (i.e. results from
gel filtration, analytical ultracentrifugation and small
angle X-ray scattering analysis). These data suggest that
HmuY oligomerization may occur at higher protein and
salt concentration [18].
Based on our data, one may expect conformational
changes occurring during heme binding to HmuY and
probably during heme release from HmuY. We propose
that HmuY first binds free heme or preferably wrests
heme bound to hemoproteins, mainly hemoglobin, and
then releases it for subsequent binding to HmuR. The
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only one of the two axial histidine ligands of HmuY. Our
previous studies showed that single replacement of
H134 or H166 by an alanine residue did not result in
abolishing heme binding, which at least in part may sup-
port this hypothesis. This reversible intramolecular co-
ordination by a histidine chain may allow heme transfer
from hemoproteins to HmuY and subsequently to
HmuR, similar to typical bacterial hemophores. It has
been shown that the hemophore HasA from Serratia
marcescens [25,26] or Pseudomonas aeruginosa [27,28]
exhibits large rearrangements, allowing heme binding
to H32 and Y75. However, a recent study demonstrated
that H32 is not conserved in all secreted hemophores. For
example, HasA from Yersinia pestis coordinates heme
with a single Y75 and its structure in both apo- and holo-
form is almost identical [29]. Thus, analysis of heme bind-
ing to HmuY is of importance in understaning heme
transfer into the P. gingivalis cell.
Conclusions
In this study we demonstrate differential roles of trypto-
phan residues played in the HmuY conformational stabil-
ity. We also hypothesize that the changes observed may
result from different tertiary structure of apo- and
holoHmuY. At least so far, we were unable to solve the
three-dimensional structure of apoHmuY, allowing de-
tailed comparison of apo- and holoforms. Therefore re-
sults gained in this study may at least in part support
our hypothesis of tertiary changes allowing heme bind-
ing to P. gingivalis HmuY.
Additional files
Additional file 1: Figure S1. Far-UV circular dichroism (CD) spectra
measured for apoHmuY (A) and holoHmuY (B) alanine variants or
apoHmuY (C) and holoHmuY (D) tyrosine variants. Protein samples at
2 μM concentration in 20 mM sodium phosphate buffer, pH 7.4 were
analyzed in a 10-mm path-length cell. The spectra were recorded over a
wavelength range of 190–260 nm. Representative data out of three
independent experiments with similar tendency are shown.
Additional file 2: Figure S2. Heme titration of HmuY alanine (A) and
tyrosine (B) variants. Heme binding was monitored by quenching of
intrinsic tryptophan fluorescence. Protein samples at 4 μM in 20 mM
sodium phosphate buffer, pH 7.4, containing 20 mM NaCl were analyzed
in 10 mm quartz cuvette. The spectra were recorded from 300 to 450 nm
at excitation at 295 nm. Representative data out of three independent
experiments with similar tendency are shown.
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